antiviral medicine additions to the registered nurse specified prescribing list
The Ministry of Health on behalf of the Director-General wants to hear your feedback on the proposed addition of two new COVID 19 antiviral medicines to the schedule of specified prescription medicines for designated registered nurse prescribers. Designated registered nurse prescribers are well positioned to support equitable and early access to appropriate COVID-19 treatment for their local communities.
The two proposed medicines (Paxlovid and Lagevrio) fit within the current registered nurse prescriber scope of practice.
Please submit your feedback on the proposed additions by 8 July 2022.